Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
about
Rapid COJEC versus standard induction therapies for high-risk neuroblastomaHeterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis.Tumor histopathological response to neoadjuvant chemotherapy in childhood solid malignancies: is it still impressive?Tumor histology during induction therapy in patients with high-risk neuroblastoma.
P2860
Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Percentage tumor necrosis foll ...... MYCN status but not survival.
@en
Percentage tumor necrosis foll ...... MYCN status but not survival.
@en-gb
Percentage tumor necrosis foll ...... MYCN status but not survival.
@nl
type
label
Percentage tumor necrosis foll ...... MYCN status but not survival.
@en
Percentage tumor necrosis foll ...... MYCN status but not survival.
@en-gb
Percentage tumor necrosis foll ...... MYCN status but not survival.
@nl
prefLabel
Percentage tumor necrosis foll ...... MYCN status but not survival.
@en
Percentage tumor necrosis foll ...... MYCN status but not survival.
@en-gb
Percentage tumor necrosis foll ...... MYCN status but not survival.
@nl
P2093
P2860
P1476
Percentage tumor necrosis foll ...... MYCN status but not survival.
@en
P2093
Beverley Davies
Deborah A Tweddle
Katrina M Wood
Leeai Chong
Michael Cole
Simon Bomken
P2860
P304
P356
10.3109/08880018.2010.526684
P577
2011-01-08T00:00:00Z